[ Amphora Medical raises $35.5M in Series B ]
Amphora Medical has raised $35.5 million in Series B funding.
Founded in 2011, Amphora Medical is a medical device manufacturer that designs and develops cystoscopic technology for the treatment of overactive bladder syndrome.
The company will use the proceeds from this financing to fund the U.S. pivotal study for its Selective Bladder Denervation System in women with OAB.
|Founder / CEO||Danny Sachs|
|Investors||F-Prime Capital Partners|
|HBM Healthcare Investments AG|
|Previous Investors||Baird Capital|